Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer
BURLINGAME, Calif. – (BUSINESS WIRE) – January 19, 2023 – Tallac Therapeutics, Inc., a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer, today announced the appointment of Kevin N. Heller, M.D., as chief medical officer.
